Skip to main content
OpenTrials

Clinical trial condition

Hidradenitis

Explore clinical trials studying Hidradenitis. Study availability and eligibility vary by location and protocol.

196 public trials 51 recruiting studies
Refine in advanced search Browse all conditions

Hidradenitis trial results

Completed

A Study to Evaluate the Efficacy, Safety, and Tolerability of Guselkumab for the Treatment of Participants With Moderate to Severe Hidradenitis Suppurativa (HS)

NCT03628924

Conditions
Bacterial Infections, Bacterial Infections and Mycoses, Hidradenitis, +8 more
Locations
  • University of Alabama Birmingham Birmingham, Alabama, United States
  • Olympian Clinical Research Largo, Florida, United States
  • Renstar Medical Research Ocala, Florida, United States
  • Park Avenue Dermatology Orange Park, Florida, United States
View all 45 locations
View Trial Details
Completed

Study to Evaluate of the Efficacy and Safety of Ruxolitinib Cream in Participants With Hidradenitis Suppurativa

NCT05635838

Conditions
Bacterial Infections, Bacterial Infections and Mycoses, Hidradenitis, +8 more
Locations
  • Medical Dermatology Specialists Phoenix Phoenix, Arizona, United States
  • First Oc Dermatology Fountain Valley, California, United States
  • Skin Care Research, Llc Scr Hollywood Boca Raton, Florida, United States
  • Forcare Clinical Research Tampa, Florida, United States
View all 20 locations
View Trial Details
Completed

This Was a Study of Efficacy and Safety of Two Secukinumab Dose Regimens in Subjects With Moderate to Severe Hidradenitis Suppurativa (HS).

NCT03713619

Conditions
Bacterial Infections, Bacterial Infections and Mycoses, Hidradenitis, +8 more
Locations
  • Novartis Investigative Site Birmingham, Alabama, United States
  • Novartis Investigative Site Rogers, Arkansas, United States
  • Novartis Investigative Site Anaheim, California, United States
  • Novartis Investigative Site San Diego, California, United States
View all 111 locations
View Trial Details
Completed

Study of Efficacy and Safety of Two Secukinumab Dose Regimens in Subjects With Moderate to Severe Hidradenitis Suppurativa (HS)

NCT03713632

Conditions
Bacterial Infections, Bacterial Infections and Mycoses, Hidradenitis, +8 more
Locations
  • Novartis Investigative Site San Diego, California, United States
  • Novartis Investigative Site Whittier, California, United States
  • Novartis Investigative Site Coral Gables, Florida, United States
  • Novartis Investigative Site Tampa, Florida, United States
View all 108 locations
View Trial Details

Related conditions